Arcus Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Arcus Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2017 to Q2 2024.
  • Arcus Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 91.1M shares, a 24.5% increase year-over-year.
  • Arcus Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 74M shares, a 2.78% increase from 2022.
  • Arcus Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 72M shares, a 3.9% increase from 2021.
  • Arcus Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 69.3M shares, a 26.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 91.1M +17.9M +24.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 86.2M +13.2M +18.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 74M +2M +2.78% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 74.6M +2.4M +3.32% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 73.2M +1.4M +1.95% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 73M +1.8M +2.53% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 72M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 72.2M +2.09M +2.98% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 71.8M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 71.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 70.1M +7.51M +12% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q4 2020 63.5M +19.7M +45% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-25
Q3 2020 62.6M +18.7M +42.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 48.6M +3.15M +6.93% Apr 1, 2020 Jun 30, 2020 10-K 2021-02-25
Q1 2020 44.3M -249K -0.56% Jan 1, 2020 Mar 31, 2020 10-K 2021-02-25
Q4 2019 43.8M +7.47M +20.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 43.9M -513K -1.15% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 45.4M +959K +2.16% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 44.5M +32.9M +284% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 36.4M +32.5M +836% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 44.5M +40.5M +1013% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 44.5M +40.6M +1040% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 11.6M +8.05M +227% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 3.89M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-05
Q3 2017 3.99M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 3.9M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 3.55M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.